dm+d

Unassigned

New Medicines

Acute kidney injury due to sepsis

Information

New molecular entity
AM-Pharma
AM-Pharma

Development and Regulatory status

Phase III Clinical Trials
Phase III Clinical Trials
Phase III Clinical Trials

Category

Endotoxin inhibitor - alkaline phosphatase detoxifies bacterial endotoxin thus reducing the sepsis cascade
UK incidence of AKI is between 486 and 630 per million, depending on definition [2]; around 40% will die of sepsis [3].
Acute kidney injury due to sepsis
Intravenous infusion